Surgery Websites
Transplant Surgery »  Meet the Team »  Transplant Surgeons »  Sandy Feng, M.D., Ph.D.

Sandy Feng, M.D., Ph.D.

Professor of Surgery
Division of Transplant Surgery
Vice Chair for Research

Contact Information

(415) 353-8725 Academic
sandy.feng@ucsf.edu 
Open Popup
  • Harvard College, B.A., Chemistry, 1979-82
  • Cambridge University, England, Ph.D., Molecular Biology, 1982-85
  • Stanford University School of Medicine, M.D., 1985-90
  • Brigham and Women's Hospital, Intern, Surgery, 1990-91
  • Brigham and Women's Hospital, Resident, Surgery, 1991-94
  • Brigham and Women's Hospital, Chief Resident, Surgery, 1994-95
  • University of California, San Francisco, Fellow, Transplant Surgery, 1996-98
  • Stanford University School of Medicine, Postdoctoral Fellow, Molecular Biology, 1986-88
  • The Whitehead Institute, MIT, Postdoctoral Fellow, Molecular Biology, 1995-96
  • American Board of Surgery, 1996
  • Clinical Fellowship, Division of Transplantation
  • The Liver Center at UCSF
  • Director, Expanded Criteria Donor Kidney Transplant Program, University of California, San Francisco
  • UCSF Hellen Diller Family Comprehensive Cancer Center
  • Expanded Criteria Donor Kidney Transplantation
  • Immunosuppression for Liver Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • MELD Allocation and Living Donor Liver Transplantation
  • Pancreas Transplantation
  • Defining the Optimal Immunosuppression for Specific Transplant Settings
  • Expanded Criteria Donors
  • Immunosuppression Withdrawal and Identification of a Profile Predictive of Tolerance
  • Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients
  • Improving Long-term Outcomes for Liver Transplant Recipients
  • Novel Immunosuppression Strategies for Liver Transplantation
  • Strategies to Decrease Ischemia Reperfusion Injury to Improve Early Graft Function after Kidney Transplantation

As Professor of Surgery and Director of the Abdominal Transplant Fellowship Program at UCSF, Dr. Sandy Feng performs liver, kidney and pancreas transplants and teaches surgical fellows, residents, and medical students. She received a doctorate in molecular biology from Cambridge University with her Marshall Scholarship and earned her medical degree at Stanford University School of Medicine. She then completed general surgery residency at the Brigham and Women's Hospital in Boston and a transplant fellowship at the University of California, San Francisco.

Dr. Feng has numerous leadership roles, including Councilor for the American Society of Transplant Surgeons, Deputy Editor for the American Journal of Transplantation, former Co-Chair of the Executive Planning Committee for the American Transplant Congress, and current Chair of the Kidney Pancreas Advisory Committee of the American Society of Transplantation. She has been an invited organizer or participant in several national consensus conferences addressing issues critical to the transplantation community.

Dr. Feng's research interest focuses on transplant immunology, with a particular focus on determinants of organ tolerance. She is also investigating novel immunosuppressive regimens and pursuing immunosuppression withdrawal in selected liver transplant recipients. By studying the immune profiles of transplant patients who are successfully weaned from immunosuppressants, she and her group hope to predict prospectively which patients may be good candidates for immunosuppression withdrawal.

Data provided by UCSF Profiles, powered by CTSI
ORCID iD: 0000-0002-2601-4350 Additional info
  • PROSPECTIVE LONGITUDINAL STUDY OF IWITH SCREEN FAILURES SECONDARY TO HISTOPATHOLOGY
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 2017
    -
    Jul 2020
    Principal Investigator
  • Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2014
    -
    May 2019
    Principal Investigator
  • Polyclonal Tregs to Promote Tolerance in Pediatric Liver Transplant Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Feb 2013
    -
    Jan 2018
    Principal Investigator
  • Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jul 2012
    -
    Jun 2017
    Principal Investigator
  • "Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
    Sponsor:
    Sponsor ID:
    Funding Period:
    Apr 2012
    -
    Mar 2014
    Principal Investigator
  • Donor-Specific Regulatory T Cell Therapy in Liver Transplantation
    Sponsor:
    Sponsor ID:
    Funding Period:
    Apr 2012
    -
    Mar 2014
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 108
Data provided by UCSF Profiles, powered by CTSI
  1. Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S. Graft fibrosis over 10 to 15 years in pediatric liver transplant recipients: Multi-center study of paired, longitudinal surveillance biopsies. Liver Transpl. 2022 Jan 13. View in PubMed
  2. Cheng K, Feng S, Bucuvalas JC, Levitsky J, Perito ER. Not everything that counts can be counted: Tracking long-term outcomes in pediatric liver transplant recipients. Am J Transplant. 2021 Dec 24. View in PubMed
  3. Lai JC, Shui AM, Duarte-Rojo A, Ganger DR, Rahimi RS, Huang CY, Yao F, Kappus M, Boyarsky B, McAdams-Demarco M, Volk ML, Dunn MA, Ladner DP, Segev DL, Verna EC, Feng S, Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Frailty, Mortality, and Healthcare Utilization after Liver Transplantation: From the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2021 Dec 04. View in PubMed
  4. Madill-Thomsen KS, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Grat M, Jurczyk K, Klintmalm G, Krasnodebski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, Myslak M, Paczek L, Perkowska-Ptasinska A, Piecha G, Reichman T, Sanchez-Fueyo A, Tronina O, Wawrzynowicz-Syczewska M, Wiecek A, Zieniewicz K, Halloran PF. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. Am J Transplant. 2021 Nov 15. View in PubMed
  5. Dixon W, Perito ER, Feng S. Baby Steps: Understanding Allograft Fibrosis in Pediatric Liver Transplantation. Liver Transpl. 2021 Sep 14. View in PubMed
  6. View All Publications

 

Site Directory
    X